Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

Is LSE:NIOX Entering a New Growth Phase Following Strong Global Asthma Testing Adoption?

NIOX Group Plc attracted significant investor attention after rising approximately 5.30% during trading on 16 June 2026. The healthcare technology company benefited from renewed investor interest in defensive growth sectors, particularly businesses with exposure to long-term healthcare demand trends, respiratory diagnostics and medical technology …

Ankur Sharma | 16 June 2026

Can Clinical Trial Progress and Licensing Opportunities Drive the Next Rally in LSE:SAR?

Sareum Holdings plc attracted significant investor attention after gaining approximately 4.35% during trading on 16 June 2026. The biotechnology company benefited from improving sentiment across healthcare and life sciences sectors as investors continued searching for innovative drug development companies with significant long-term growth potential.

Ankur Sharma | 16 June 2026

Can Commercial Progress Drive Shield Therapeutics Growth?

Shield Therapeutics Plc (LSE:STX) has established itself as one of the standout performers among UK stocks over the past 12 months, delivering a remarkable 1-year share price gain of approximately 161.22% based on TradingView screener data. At the time of writing, STX shares are …

Divya Sood | 16 June 2026

Can Abingdon Health Bounce Back from Weak Sentiment?

Key Takeaways (June 2026)• ABDX stock has fallen 1.08% amid muted healthcare small-cap sentiment• UK diagnostics and biotech microcaps remain highly volatile• AIM healthcare stocks continue to face liquidity-driven swings• Investor focus remains on funding and commercial traction• Defensive healthcare names show mixed performance …

Ankur Sharma | 16 June 2026

Is Creo Medical Undervalued Compared to Other AIM Healthcare Stocks?

Key TakeawaysCreo Medical Group (CREO) appeared in a TradingView Top Gaining UK Stocks snapshot, rising 3.77% to 13.75 GBX on relative volume of 0.83 - slightly below its typical level - with around 661,390 shares traded.The supportive backdrop includes reported revenue growth of around …

Ankur Sharma | 16 June 2026

Could Regulatory Progress Be the Next Catalyst for Cizzle Biotechnology Stock?

Cizzle Biotechnology Holdings plc (LSE:CIZ) was one of the standout names among UK stocks on the move, appearing in a TradingView "Top Gaining UK Stocks" snapshot of the day's biggest UK market movers. The shares were marked up by 6.78% to 3.15 pence (GBX), …

Ankur Sharma | 16 June 2026

LSE:CIZ – Could the CIZ1B Blood Test Become a Game Changer in Early Lung Cancer Detection?

Cizzle Biotechnology Holdings has emerged as one of the most closely watched UK healthcare and biotechnology stocks after a series of significant commercial, regulatory and intellectual property developments linked to its proprietary CIZ1B lung cancer diagnostic platform. The company is focused on developing non-invasive …

Ankur Sharma | 16 June 2026

Is Halma plc Becoming One Of The Strongest Long-Term Buy-And-Hold Stocks In The UK Market?

Halma plc was among the strongest-performing FTSE 100 stocks on 15 June 2026, rising 4.74% as investors continued allocating capital toward high-quality defensive growth businesses capable of delivering earnings resilience across economic cycles.

Ankur Sharma | 15 June 2026

Is Halma plc Becoming One Of The Strongest Long-Term Buy-And-Hold Stocks In The UK Market?

Halma plc was among the strongest-performing FTSE 100 stocks on 15 June 2026, rising 4.74% as investors continued allocating capital toward high-quality defensive growth businesses capable of delivering earnings resilience across economic cycles.

Ankur Sharma | 15 June 2026

Can Fusion Antibodies Plc Turn Innovation into Sustainable Revenue Growth?

Fusion Antibodies Plc operates in the biotechnology sector and specializes in antibody discovery, engineering, optimization, and humanization services. The company serves pharmaceutical and biotechnology clients involved in developing next-generation antibody-based therapeutics.

Ishan Mudgal | 15 June 2026
Support

Hi! How can we help you today?

Loading…